inTEST

inTEST reported Q2 FY2026. EPS came in at $0.09 against a $0.05 consensus, beat by 92.7%. Revenue was $35.3M versus $35.0M expected, beat by 1.0%. Gross margin was 40.6%, down 260 bps from last quarter.

inTEST delivered a clean revenue beat and in-line street EPS, but the more important message is that management is guiding growth without assuming a meaningful semiconductor rebound. The stock debate should shift from whether Q4 was helped by catch-up revenue to whether backlog, diversification, and manufacturing efficiency can sustain margins as mix normalizes.

inTEST missed the street by -16.3% on revenue and flipped to an adjusted loss, but the variant view is that the print is less about end-market demand collapsing and more about whether management can convert a backlog that reached $49.3 million after orders hit $37.6 million. The market was priced for a modest profit on $31.4 million of revenue; what surprised was not just the $26.2 million revenue base, but the fact that approximately $2 million of delayed shipments did not translate into a Q4 guide as large as the slip would mechanically imply.

inTEST missed the revenue bar, but the print was better than the headline because cost actions and non-semi demand turned an expected loss into adjusted profit. The market may be mispricing this as a low-quality small-cap beat, when the more relevant signal is that backlog held at $37.9 million while auto/EV and new-product demand are replacing the acquired Alfamation runoff.